Noesis Capital Mangement’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.9M | Buy |
126,232
+11,003
| +10% | +$1.45M | 1.92% | 21 |
|
|
2026
Q1 | $16.1M | Sell |
115,229
-34
| -0% | -$4.76K | 2.37% | 20 |
|
|
2025
Q4 | $14.1M | Buy |
115,263
+745
| +0.7% | +$90.5K | 2.05% | 19 |
|
|
2025
Q3 | $12.7M | Buy |
114,518
+943
| +0.8% | +$107K | 1.97% | 20 |
|
|
2025
Q2 | $12.6M | Buy |
113,575
+116
| +0.1% | +$12.3K | 2.19% | 19 |
|
|
2025
Q1 | $12.7M | Sell |
113,459
-1,380
| -1% | -$142K | 2.53% | 16 |
|
|
2024
Q4 | $10.6M | Sell |
114,839
-1,274
| -1% | -$115K | 2.02% | 20 |
|
|
2024
Q3 | $9.73M | Buy |
116,113
+4,425
| +4% | +$338K | 1.93% | 21 |
|
|
2024
Q2 | $7.66M | Buy |
111,688
+20
| +0% | +$1.33K | 1.7% | 25 |
|
|
2024
Q1 | $8.18M | Buy |
111,668
+5,223
| +5% | +$402K | 1.82% | 24 |
|
|
2023
Q4 | $8.62M | Sell |
106,445
-1,408
| -1% | -$110K | 2.03% | 22 |
|
|
2023
Q3 | $8.08M | Buy |
107,853
+507
| +0.5% | +$39K | 2.12% | 22 |
|
|
2023
Q2 | $8.27M | Buy |
107,346
+118
| +0.1% | +$9.41K | 2.04% | 24 |
|
|
2023
Q1 | $8.9M | Buy |
107,228
+4,325
| +4% | +$358K | 2.25% | 18 |
|
|
2022
Q4 | $8.83M | Sell |
102,903
-4,201
| -4% | -$333K | 2.51% | 16 |
|
|
2022
Q3 | $6.61M | Sell |
107,104
-493
| -0.5% | -$31.1K | 2% | 22 |
|
|
2022
Q2 | $6.65M | Sell |
107,597
-1,622
| -1% | -$100K | 1.97% | 23 |
|
|
2022
Q1 | $6.49M | Sell |
109,219
-1,099
| -1% | -$70.3K | 1.56% | 25 |
|
|
2021
Q4 | $8.01M | Sell |
110,318
-15,554
| -12% | -$1.07M | 1.61% | 26 |
|
|
2021
Q3 | $8.79M | Buy |
125,872
+1,699
| +1% | +$119K | 1.72% | 25 |
|
|
2021
Q2 | $8.52M | Buy |
124,173
+315
| +0.3% | +$21K | 1.74% | 24 |
|
|
2021
Q1 | $8.01M | Sell |
123,858
-3,440
| -3% | -$222K | 1.8% | 26 |
|
|
2020
Q4 | $7.42M | Sell |
127,298
-3,230
| -2% | -$195K | 1.83% | 23 |
|
|
2020
Q3 | $8.25M | Sell |
130,528
-2,882
| -2% | -$200K | 2.34% | 22 |
|
|
2020
Q2 | $10.3M | Sell |
133,410
-6,241
| -4% | -$478K | 3.25% | 13 |
|
|
2020
Q1 | $10.4M | Buy |
139,651
+373
| +0.3% | +$25.8K | 3.84% | 6 |
|
|
2019
Q4 | $9.05M | Buy |
139,278
+874
| +0.6% | +$56.9K | 2.52% | 17 |
|
|
2019
Q3 | $8.77M | Buy |
138,404
+931
| +0.7% | +$60.9K | 2.84% | 17 |
|
|
2019
Q2 | $9.29M | Buy |
137,473
+926
| +0.7% | +$60.9K | 3.16% | 14 |
|
|
2019
Q1 | $8.88M | Buy |
136,547
+37,112
| +37% | +$2.47M | 3.21% | 13 |
|
|
2018
Q4 | $6.22M | Buy |
99,435
+1,549
| +2% | +$108K | 2.52% | 19 |
|
|
2018
Q3 | $7.56M | Buy |
97,886
+4,781
| +5% | +$361K | 2.65% | 18 |
|
|
2018
Q2 | $6.6M | Sell |
93,105
-9,742
| -9% | -$688K | 2.42% | 19 |
|
|
2018
Q1 | $7.75M | Buy |
102,847
+2,528
| +3% | +$201K | 2.87% | 15 |
|
|
2017
Q4 | $7.19M | Sell |
100,319
-1,705
| -2% | -$129K | 2.59% | 15 |
|
|
2017
Q3 | $8.27M | Sell |
102,024
-1,724
| -2% | -$132K | 3.1% | 11 |
|
|
2017
Q2 | $7.34M | Sell |
103,748
-2,107
| -2% | -$140K | 2.81% | 14 |
|
|
2017
Q1 | $7.19M | Sell |
105,855
-2,284
| -2% | -$161K | 2.74% | 15 |
|
|
2016
Q4 | $7.74M | Buy |
108,139
+40,029
| +59% | +$2.98M | 3.23% | 8 |
|
|
2016
Q3 | $5.39M | Buy |
68,110
+1,585
| +2% | +$129K | 2.32% | 21 |
|
|
2016
Q2 | $5.55M | Buy |
66,525
+726
| +1% | +$64.4K | 2.47% | 17 |
|
|
2016
Q1 | $6.04M | Buy |
65,799
+827
| +1% | +$74.6K | 2.75% | 15 |
|
|
2015
Q4 | $6.58M | Buy |
64,972
+1,655
| +3% | +$172K | 3.12% | 11 |
|
|
2015
Q3 | $6.22M | Sell |
63,317
-6,070
| -9% | -$674K | 3.29% | 13 |
|
|
2015
Q2 | $8.12M | Sell |
69,387
-776
| -1% | -$84.8K | 3.5% | 5 |
|
|
2015
Q1 | $6.88M | Buy |
70,163
+715
| +1% | +$72.6K | 2.85% | 11 |
|
|
2014
Q4 | $6.55M | Buy |
69,448
+6,995
| +11% | +$723K | 2.74% | 14 |
|
|
2014
Q3 | $6.65M | Sell |
62,453
-3,411
| -5% | -$334K | 2.89% | 11 |
|
|
2014
Q2 | $5.46M | Buy |
65,864
+58,048
| +743% | +$4.52M | 2.47% | 15 |
|
|
2014
Q1 | $554K | Buy |
7,816
+1,888
| +32% | +$148K | 0.27% | 78 |
|
|
2013
Q4 | $445K | Sell |
5,928
-3,121
| -34% | -$217K | 0.22% | 82 |
|
|
2013
Q3 | $569K | Hold |
9,049
| – | – | 0.3% | 77 |
|
|
2013
Q2 | $464K | Buy |
+9,049
| New | +$472K | 0.25% | 85 |
|
Other funds holding GILD
Noesis Capital Mangement's GILD Position: Q2 2026 in Review
Noesis Capital Mangement increased its Gilead Sciences (GILD) stake by 9.5% in Q2 2026, buying an estimated $1.45M and bringing the position to 126,232 shares worth $15.9M. The position accounts for 1.92% of the portfolio, ranked #21.
Noesis Capital Mangement first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.1M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Noesis Capital Mangement held 126,232 shares of Gilead Sciences worth $15.9M as of Q2 2026.
- Noesis Capital Mangement bought 11,003 Gilead Sciences shares in Q2 2026, an estimated $1.45M.
- Gilead Sciences made up 1.92% of Noesis Capital Mangement's portfolio in Q2 2026, its #21 holding.
- Noesis Capital Mangement first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Noesis Capital Mangement's Gilead Sciences position peaked at $16.1M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Noesis Capital Mangement's 13F filing for Q2 2026, filed 4 Aug 2026.